Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
MAXOMAT, biosynthetic growth hormone · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| MAXOMAT ®, biosynthetic growth hormone | DRUG | 2 posologies according to age (children and adolescents) treatment is planned for a 2 year duration |
Inclusion Criteria: * Children and adolescents with Noonan's syndrome with a height \< -2 SD and no progressive cardiopathy Exclusion Criteria: * Age \< 3 years * Height ≥ -2 SD The above information is not intended to contain all considerations relevant to a patient's potential participation in...
MAXOMAT, a biosynthetic growth hormone, is used to improve growth in small children with Noonan Syndrome. It is being developed by Sanofi and is currently in Phase 3 clinical development. The drug is intended to address growth deficits associated with this rare genetic condition.
MAXOMAT is a biosynthetic growth hormone, meaning it acts as a replacement for naturally occurring human growth hormone. It works by supplementing growth hormone levels in the body to promote linear growth in children with Noonan Syndrome who have short stature.
MAXOMAT is developed by Sanofi, a global biopharmaceutical company listed on the stock exchange under the ticker symbol SNY. Sanofi is conducting clinical research to evaluate the safety and efficacy of MAXOMAT in treating growth issues associated with Noonan Syndrome.
MAXOMAT is in Phase 3 clinical development. It has completed one Phase 3 trial, which was an uncontrolled study involving 36 participants with Noonan Syndrome. The drug is investigational and has not yet been approved by regulatory authorities for commercial use.
MAXOMAT has been studied in one clinical trial registered under NCT00452725, titled 'Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome'. This Phase 3 trial was completed in France and enrolled 36 children aged 3 years and older with Noonan Syndrome.
Yes, MAXOMAT is a biosynthetic growth hormone. It is a laboratory-produced version of human growth hormone, designed to mimic the natural hormone's effects. This makes it distinct from growth hormones derived from human or animal sources, offering a more consistent and controlled treatment option.